Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mimi Ton has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Supplementary Table S1 from Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Supplementary Table S1 provides definitions of each alcohol variable along with the weighted prevalence estimates for each.

  • Open Access

    Data from Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Background:Alcohol is a risk factor for cancer and may pose unique risks for cancer survivors. Population-based studies of confirmed cancer cases are needed to estimate the extent of drinking among cancer survivors and to understand which survivors are most at risk of alcohol-related health problems.Methods:Cancer survivors who resided in the Puget Sound Surveillance, Epidemiology, and End Results (SEER) region, were ages 21 to 74 years at diagnosis, and were 6 to 17 months post-diagnosis at the start of the recruitment period (April 2020–December 2020) were sent a survey that included demographics, substance use, mental health, and cancer-related items. Data from returned surveys (n = 1,488) were weighted to represent the characteristics of the Puget Sound SEER region. We estimated the prevalence of post-diagnosis alcohol use as well as demographic, behavioral, and clinical correlates of three levels of drinking: any drinking, drinking exceeding cancer prevention guidelines, and hazardous drinking.Results:The weighted prevalence of any drinking, drinking exceeding cancer prevention guidelines, and hazardous drinking was 71%, 46.2%, and 31.6%, respectively. Higher income and cannabis use were associated with increased odds of all three drinking levels. Lower physical health quality of life, having non-colorectal gastrointestinal cancer, and receiving chemotherapy within the last month were associated with decreased odds of all three drinking levels.Conclusions:The prevalence of any drinking and at-risk drinking was higher than in previous studies and differed based on sociodemographic, substance use, and cancer-related factors.Impact:Findings highlight the importance of identifying and addressing risky alcohol use in cancer care settings.

  • Open Access

    Supplementary Table S1 from Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Supplementary Table S1 provides definitions of each alcohol variable along with the weighted prevalence estimates for each.

  • Open Access

    Supplementary Table S3 from Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Supplementary Table S3 provides the unadjusted odds ratios and 95% confidence intervals from separate, unweighted, sex- stratified models of post-diagnosis alcohol use in relation to cancer site

  • Open Access

    Data from Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Background:Alcohol is a risk factor for cancer and may pose unique risks for cancer survivors. Population-based studies of confirmed cancer cases are needed to estimate the extent of drinking among cancer survivors and to understand which survivors are most at risk of alcohol-related health problems.Methods:Cancer survivors who resided in the Puget Sound Surveillance, Epidemiology, and End Results (SEER) region, were ages 21 to 74 years at diagnosis, and were 6 to 17 months post-diagnosis at the start of the recruitment period (April 2020–December 2020) were sent a survey that included demographics, substance use, mental health, and cancer-related items. Data from returned surveys (n = 1,488) were weighted to represent the characteristics of the Puget Sound SEER region. We estimated the prevalence of post-diagnosis alcohol use as well as demographic, behavioral, and clinical correlates of three levels of drinking: any drinking, drinking exceeding cancer prevention guidelines, and hazardous drinking.Results:The weighted prevalence of any drinking, drinking exceeding cancer prevention guidelines, and hazardous drinking was 71%, 46.2%, and 31.6%, respectively. Higher income and cannabis use were associated with increased odds of all three drinking levels. Lower physical health quality of life, having non-colorectal gastrointestinal cancer, and receiving chemotherapy within the last month were associated with decreased odds of all three drinking levels.Conclusions:The prevalence of any drinking and at-risk drinking was higher than in previous studies and differed based on sociodemographic, substance use, and cancer-related factors.Impact:Findings highlight the importance of identifying and addressing risky alcohol use in cancer care settings.

  • Open Access

    Supplementary Table S2 from Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Supplementary Table S2 provides the unadjusted odds ratios and 95% confidence intervals from unweighted models evaluating each personal, clinical, and social characteristic separately in relation to post-diagnosis alcohol use (n=1,488)

  • Open Access

    Supplementary Table S2 from Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Supplementary Table S2 provides the unadjusted odds ratios and 95% confidence intervals from unweighted models evaluating each personal, clinical, and social characteristic separately in relation to post-diagnosis alcohol use (n=1,488)

  • Open Access

    Supplementary Table S3 from Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Supplementary Table S3 provides the unadjusted odds ratios and 95% confidence intervals from separate, unweighted, sex- stratified models of post-diagnosis alcohol use in relation to cancer site

  • Open Access

    Spatiotemporal light exposure modeling for environmental circadian misalignment and solar jetlag

    by Trang VoPham, Mimi Ton, Matthew D. Weaver

    Background: Light exposure is the most powerful resetting signal for circadian rhythms. The objective of this study was to develop and validate a high-resolution geospatial light exposure model that measures environmental circadian misalignment (or solar jetlag) as the mismatch between the social clock and sun clock, which occurs from geographic variation in light exposure leading to delayed circadian phase from relatively less morning light exposure and greater evening light exposure with increasing westward position within a time zone. Methods: The light exposure model (30 m2 spatial resolution) incorporated geospatial data across the United States on time zones, elevation (using Google Earth Engine), sunrise time, and sunset time to estimate solar jetlag scores (higher values indicate higher environmental circadian misalignment). The validation study compared the light exposure model in 2022, which was linked with geocoded residential addresses of n = 20 participants in Boston, MA (eastern time zone position) and Seattle, WA (western time zone position) using a geographic information system, with illuminance values captured from wearable LYS light sensors and with sun times from the Solar Calculator. Results: Western versus eastern positions within a time zone were associated with higher solar jetlag scores from the light exposure model (P < 0.01) and relatively larger differences in sunset time measured using light sensors (social clock) and the Solar Calculator (sun clock) (P = 0.04). Conclusion: We developed and validated a geospatial light exposure model, enabling high spatiotemporal resolution and comprehensive characterization of geographic variation in light exposure potentially impacting circadian phase in epidemiologic studies.


  • Prevalence and Correlates of Post-Diagnosis Alcohol Use among Cancer Survivors

    by Jaimee L. Heffner, Mimi Ton, Salene M.W. Jones, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

    Background: Alcohol is a risk factor for cancer and may pose unique risks for cancer survivors. Population-based studies of confirmed cancer cases are needed to estimate the extent of drinking among cancer survivors and to understand which survivors are most at risk of alcohol-related health problems. Methods: Cancer survivors who resided in the Puget Sound Surveillance, Epidemiology, and End Results (SEER) region, were ages 21 to 74 years at diagnosis, and were 6 to 17 months post-diagnosis at the start of the recruitment period (April 2020–December 2020) were sent a survey that included demographics, substance use, mental health, and cancer-related items. Data from returned surveys (n = 1,488) were weighted to represent the characteristics of the Puget Sound SEER region. We estimated the prevalence of post-diagnosis alcohol use as well as demographic, behavioral, and clinical correlates of three levels of drinking: any drinking, drinking exceeding cancer prevention guidelines, and hazardous drinking. Results: The weighted prevalence of any drinking, drinking exceeding cancer prevention guidelines, and hazardous drinking was 71%, 46.2%, and 31.6%, respectively. Higher income and cannabis use were associated with increased odds of all three drinking levels. Lower physical health quality of life, having non-colorectal gastrointestinal cancer, and receiving chemotherapy within the last month were associated with decreased odds of all three drinking levels. Conclusions: The prevalence of any drinking and at-risk drinking was higher than in previous studies and differed based on sociodemographic, substance use, and cancer-related factors. Impact: Findings highlight the importance of identifying and addressing risky alcohol use in cancer care settings.